Sveinn Sölvason, President and CEO, comments: “We delivered our highest ever quarterly sales in Q2 2024 with sales amounting to USD 217 million. Organic growth stood at 6% for Q2 with continued strong momentum in EMEA, driven by a strong performance in Prosthetics & Neuro Orthotics and Patient Care. Our profitability was strong for the quarter with an EBITDA margin of 22%."

Embla will host a conference call on July 23, 2024, at 09:00 CET / 7:00 GMT / 3:00 EST.

A webcast can be followed by clicking the link below:

To actively participate in the Q&A session of the conference call, please click on this link:

To view or download the investor presentation & company announcement, please visit our Reports & Presentations page.

Latest Announcements and News

Recent IR News

Q2 2024 Results
Please visit the relevant documents below for more information:

Company Announcement

Investor Presentation

Company Profile


Share Information and Results

Financial Calendar and Events

Email Subscription
To stay up-to-date with our latest investor email alerts, please sign up.
General Inquiries

Klaus Sindahl, Head of Investor Relations

Email: [email protected]
Telephone number: +4553630134